Literature DB >> 9373099

Early treatment of posterior retinopathy of prematurity: a controlled trial.

J F Vander1, J Handa, J A McNamara, M Trese, R Spencer, M X Repka, P Rubsamen, H Li, L S Morse, W S Tasman.   

Abstract

OBJECTIVE: The purpose of the study is to assess the possible benefits of early laser treatment for posterior retinopathy of prematurity (ROP) and to provide data concerning the natural history of posterior ROP.
DESIGN: The study design was a prospective, multicenter, randomized trial. PARTICIPANTS: A total of 19 infants with prethreshold posterior ROP were studied. INTERVENTION: Randomization to immediate indirect laser photocoagulation or observation, with application of laser photocoagulation for those control eyes reaching threshold disease, was performed. MAIN OUTCOME MEASURES: Patients were assessed at 3 months and the anatomic outcome recorded along with any adverse treatment effects.
RESULTS: An unfavorable structural outcome developed in 3 (16%) of 19 early treatment eyes compared with 3 (18%) of 17 for those treated only if threshold disease was reached. Of the 17 control eyes, 15 (88%) reached threshold disease. Progression to threshold occurred within 1 week in all but two eyes. All 12 control eyes with posterior ROP and any amount of extraretinal fibrovascular proliferation progressed to threshold disease.
CONCLUSIONS: Although the number of patients studied is too small to reach statistical significance, the likelihood of a favorable outcome for eyes with prethreshold posterior ROP treated immediately with laser photocoagulation is comparable to that obtained by withholding treatment until threshold disease is reached. There is a high probability of progression from prethreshold to threshold disease, usually within 1 week or less.

Entities:  

Mesh:

Year:  1997        PMID: 9373099     DOI: 10.1016/s0161-6420(97)30034-7

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  10 in total

1.  Diode laser treatment of posterior retinopathy of prematurity.

Authors:  R Axer-Siegel; M Snir; D Cotlear; A Maayan; R Frilling; I Rosenbaltt; D Weinberger; I Kremer; L Sirota
Journal:  Br J Ophthalmol       Date:  2000-12       Impact factor: 4.638

2.  [Comparison of the anatomical and functional outcome after laser or cryotherapy for retinopathy of prematurity (ROP)].

Authors:  C Jandeck; U Kellner; H Heimann; M H Foerster
Journal:  Ophthalmologe       Date:  2005-01       Impact factor: 1.059

3.  The effect of early treatment at the initial stage 3 moderate phase of retinopathy of prematurity on severe retinal changes.

Authors:  Yoshikazu Hatsukawa; Nami Ueki; Tomoko Yamagishi; Hiroyuki Kitajima
Journal:  Jpn J Ophthalmol       Date:  2005 Sep-Oct       Impact factor: 2.447

4.  Treated threshold stage 3 versus spontaneously regressed subthreshold stage 3 retinopathy of prematurity: a study of motility, refractive, and anatomical outcomes at 6 months and 36 months.

Authors:  J Sahni; N V Subhedar; D Clark
Journal:  Br J Ophthalmol       Date:  2005-02       Impact factor: 4.638

Review 5.  Advances in understanding and management of retinopathy of prematurity.

Authors:  Mary Elizabeth Hartnett
Journal:  Surv Ophthalmol       Date:  2016-12-22       Impact factor: 6.048

6.  Comparison of Intravitreal Anti-VEGF Agents With Laser Photocoagulation for Retinopathy of Prematurity of 1,627 Eyes in China.

Authors:  Dandan Linghu; Yong Cheng; Xuemei Zhu; Xun Deng; Hong Yin; Yanrong Jiang; Mingwei Zhao; Xiaoxin Li; Jianhong Liang
Journal:  Front Med (Lausanne)       Date:  2022-05-31

7.  Final results of the Early Treatment for Retinopathy of Prematurity (ETROP) randomized trial.

Authors:  William V Good
Journal:  Trans Am Ophthalmol Soc       Date:  2004

Review 8.  Screening and Treatment in Retinopathy of Prematurity.

Authors:  Andreas Stahl; Wolfgang Göpel
Journal:  Dtsch Arztebl Int       Date:  2015-10-23       Impact factor: 5.594

9.  Automated Explainable Multidimensional Deep Learning Platform of Retinal Images for Retinopathy of Prematurity Screening.

Authors:  Ji Wang; Jie Ji; Mingzhi Zhang; Jian-Wei Lin; Guihua Zhang; Weifen Gong; Ling-Ping Cen; Yamei Lu; Xuelin Huang; Dingguo Huang; Taiping Li; Tsz Kin Ng; Chi Pui Pang
Journal:  JAMA Netw Open       Date:  2021-05-03

Review 10.  Translational Research in Retinopathy of Prematurity: From Bedside to Bench and Back Again.

Authors:  Mitsuru Arima; Yuya Fujii; Koh-Hei Sonoda
Journal:  J Clin Med       Date:  2021-01-18       Impact factor: 4.241

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.